Clinical Trial Update: Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing basal-bolus insulin against basal insulin plus a GLP-1 analogue assessing hypoglycemia risk during transition from inpatient to outpat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• basal insulin plus GLP-1 analogue (GLP-1 receptor agonist)
• basal-bolus insulin (basal-bolus insulin regimen)

Snippet

Sponsor: Hospital Universitario San Ignacio | Conditions: Diabetes Mellitus, Type 2 Treated With Insulin | Phase 3 | Status: UNKNOWN